Project Grant R44AG097250
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), has awarded a $499,651 project grant to Carevirtue Technologies, Inc. to develop a novel, AI-enabled dementia care agent. This agent will provide 24/7 personalized education and support services to rural caregivers of individuals with Alzheimer's disease and related dementias (ADRD). The goal is to address the higher caregiving burden and lower social support experienced by rural ADRD care...
- The National Institute on Aging (NIA) awarded Mentia DTX Inc., a digital health company focused on Alzheimer's disease and related dementias (ADRD), a $505,561 Project Grant under the Aging Research program (CFDA 93.866) to develop an AI-based virtual companion system called "MentiaCompanion." This system aims to track changing health states in persons living with dementia, enabling connected care and early detection of acute health events to facilitate timely clinical intervention....
- The National Institute on Aging (NIA) awarded a $1,010,368 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Koronis Biomedical Technologies Corp. (KBT) to develop and validate an interactive gaming platform to facilitate cognitive interventions for individuals living with mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (AD/ADRD). The goal is to create an in-home cognition training system that provides evidence-based cognitive activities...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $506,399 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to Healthy Design LTD. CO. to develop a novel continuous predictive wearable agitation monitor and alert system using actigraphy and AI for hospitalized older adults. The goal is to prevent delirium and dementia by closely monitoring agitation levels and enabling timely implementation of non-harmful...
- The U.S. National Institute on Aging (NIA) awarded a $1,089,329 Project Grant to Homecare Hub US Inc. under the Aging Research Federal Grant Program (CFDA 93.866) to scale a network of small community-based care homes as a high-value alternative to institutional long-term care. The project aims to demonstrate improved health outcomes for seniors by leveraging a technology platform that facilitates personalized, cost-effective care through a decentralized network of 2-12 person residential care...
- The National Institute on Aging (NIA) awarded a $490,262 Project Grant under the Aging Research program (CFDA 93.866) to Plans4Care Inc. to develop and test a digital platform called Activities4Care. The platform aims to provide customized, evidence-based activities to enhance the well-being of caregivers and improve quality of life for people living with Alzheimer's disease and related dementias. The 1-year project will create a clickable prototype mapping activities to the characteristics of...
- The National Institute on Aging, under the Aging Research federal grant program (CFDA 93.866), awarded Careyaya Health Technologies Inc. a $505,042 Project Grant on Sep 22, 2025. The grant supports the development of YAYAGUIDE, an artificial intelligence (AI)-driven, personalized training platform for caregivers of individuals with Alzheimer's disease and related dementias. The YAYAGUIDE prototype utilizes a micro-learning curriculum, a conversational agent, and machine learning algorithms to...
- This Project Grant award of $326,382 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is for the development and testing of "SEEINME" - a consumer-generated, HIPAA-compliant digital personal health profile for persons with dementia (PWD). The goal is to foster person-centered coordinated care and reduce caregiver burden by enabling assisted living/memory care communities to partner with and empower family members, informal...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $1,249,957 Project Grant under CFDA 93.866 (Aging Research) to Advantage Therapeutics, Inc. in Florida. The grant aims to perform IND-enabling studies on a small molecule that is disease-modifying, low-cost, and has a long safety record for the treatment of Alzheimer's disease. The proposed molecule is designed to reduce brain inflammation and restore phagocytosis, thereby improving the...
The National Institute on Aging (NIA) awarded Hido Technologies, Inc. a $1,240,765 Project Grant (CFDA 93.866 - Aging Research) to develop an internet-connected, self-medicating device with video direct observed therapy (VDOT) capabilities. The goal is to improve medication adherence and cognitive outcomes for persons with Alzheimer's disease and related dementias (AD/ADRD), while also reducing caregiver burden and healthcare costs. The device, called Homecare, integrates with a novel pharmacy distribution system to securely manage and monitor medication administration. Through a two-arm randomized controlled trial, the project aims to validate the system's ability to enhance adherence, cognitive function, and caregiver support for patients with dementia. The award period runs from Sep 20, 2025 to May 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 9/18/25 |